These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10917074)

  • 1. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.
    Kulisevsky J
    Drugs Aging; 2000 May; 16(5):365-79. PubMed ID: 10917074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease.
    Moustafa AA; Herzallah MM; Gluck MA
    Neurodegener Dis; 2013; 11(2):102-11. PubMed ID: 23128796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
    Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
    Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levodopa and cognitive disorders in Parkinson's disease].
    Leiva-Santana C; Alvarez-Saúco M
    Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and the regulation of cognition and attention.
    Nieoullon A
    Prog Neurobiol; 2002 May; 67(1):53-83. PubMed ID: 12126656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
    Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
    Kulisevsky J; García-Sánchez C; Berthier ML; Barbanoj M; Pascual-Sedano B; Gironell A; Estévez-González A
    Mov Disord; 2000 Jul; 15(4):613-26. PubMed ID: 10928571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional brain imaging of cognitive dysfunction in Parkinson's disease.
    Hirano S; Shinotoh H; Eidelberg D
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):963-9. PubMed ID: 22807560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
    Pillon B; Dubois B; Cusimano G; Bonnet AM; Lhermitte F; Agid Y
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):201-6. PubMed ID: 2703838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of the default mode network in Parkinson's disease.
    Delaveau P; Salgado-Pineda P; Fossati P; Witjas T; Azulay JP; Blin O
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):784-92. PubMed ID: 20674286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of prospective memory in Parkinson's disease.
    Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
    Behav Neurol; 2008; 19(1-2):45-8. PubMed ID: 18413916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms.
    Babiloni C; Del Percio C; Lizio R; Noce G; Lopez S; Soricelli A; Ferri R; Pascarelli MT; Catania V; Nobili F; Arnaldi D; Famà F; Orzi F; Buttinelli C; Giubilei F; Bonanni L; Franciotti R; Onofrj M; Stirpe P; Fuhr P; Gschwandtner U; Ransmayr G; Fraioli L; Parnetti L; Farotti L; Pievani M; D'Antonio F; De Lena C; Güntekin B; Hanoğlu L; Yener G; Emek-Savaş DD; Triggiani AI; Taylor JP; McKeith I; Stocchi F; Vacca L; Frisoni GB; De Pandis MF
    Neurobiol Aging; 2019 Jan; 73():9-20. PubMed ID: 30312790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.